Also known as: Permax Mesylate; LY-127809 Mesylate; Pergolide Methanesulfonate
Pergolide Mesylate is the methanesulfonate salt of Pergolide, the ergoline dopamine agonist. Mediocon Inc manufactures this high-purity API at its GMP-certified facility in Aurangabad, Maharashtra, India. The mesylate salt form provides improved pharmaceutical stability and solubility compared to the free base. Pergolide Mesylate was the commercially approved form (Permax) and remains widely used in veterinary medicine for equine PPID. It exhibits potent D1 and D2 receptor agonist activity.
| Parameter | Specification |
|---|---|
| CAS Number | 66104-23-2 |
| Molecular Formula | C₂₀H₃₀N₂O₃S₂ |
| Molecular Weight | 410.59 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Dopamine Agonist / Antiparkinsonian |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | PGM/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Pergolide Mesylate — CAS 66104-23-2 (CAS 66104-23-2) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Pergolide Mesylate — CAS 66104-23-2 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance